comparemela.com
Home
Live Updates
FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges - Laying groundwork for high-quality evidence to support regulatory decisions | Hogan Lovells : comparemela.com
FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges - Laying groundwork for high-quality evidence to support regulatory decisions | Hogan Lovells
This month, FDA released the latest in a series of agency guidance to advance the development and use of real-world data (RWD) and real-world evidence (RWE) in clinical trial designs...
Related Keywords
United States
,
Americans
,
Robert Califf
,
Stephen Hahn
,
Hogan Lovells
,
Scott Gottlieb
,
,
Commissioners Stephen Hahn
,
Century Cures Act
,
Cures Act
,
Biological Product Submissions
,
World Data
,
Assessing Registries
,
Support Regulatory Decision Making
,
Biological Products
,
comparemela.com © 2020. All Rights Reserved.